Mosaic Biosciences’ Post

𝑻𝒊𝒄𝒌-𝒕𝒐𝒄𝒌! 𝐉𝐮𝐬𝐭 𝐟𝐞𝐰 𝐡𝐨𝐮𝐫𝐬 𝐥𝐞𝐟𝐭 until the 23rd Drug Discovery Innovation Programme Conference kicks off! 🕒𝑮𝒆𝒕 𝒔𝒆𝒕 𝒇𝒐𝒓 𝒂 𝒈𝒓𝒐𝒖𝒏𝒅𝒃𝒓𝒆𝒂𝒌𝒊𝒏𝒈 𝒋𝒐𝒖𝒓𝒏𝒆𝒚 𝒊𝒏 𝒅𝒓𝒖𝒈 𝒅𝒊𝒔𝒄𝒐𝒗𝒆𝒓𝒚 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏. Don't miss out! #fewhoursleft #drugdiscovery #innovation #genomics  #sciencestudent #steam #scientist #phdresearch #biologics #medicinalchem #drugdiscovery #oncology #bioinformatics #genomics #medicinalchemistry #licensing #drugdiscoveryconference2024 #industryexperts #ddip24 World BI

📅 Save the date: September 7, 2023 📣Oncofactory is delighted to invite you to join its second #webinar with ERBC (European Research Biology Center) to discuss the non-clinical application of the avian embryo model (AVI-PDX™) with guest speaker from biotech Karine Agueraéra, Chief Development Officer at StromaCare, previously R&D Project leader at ERYTECH Pharma. 👉 Register here: https://lnkd.in/e9rJWMFA This interactive webinar will address your burning questions in an engaging Q&A format and will feature a case study exploring the non-clinical applications of our methodology to generate patient tumor replicates in #avian embryos (AVI-PDX™). We will discuss published scientific data, highlighting the design of the #breastcancer model and its application in non-clinical studies, with potential implications for other cancers. Additionally, we will explore the real-world application of the model by a biopharmaceutical company to build a strong preclinical package for regulatory authorities. Can't make it on September 7th? Register anyway and get access to the session replay. Also, mark your calendars for our third webinar on September 28, 2023, where we will delve into clinical case studies. We look forward to engaging discussions with you during this webinar. For more information on the Oncofactory platform overview and to replay Webinar 1, click here: https://lnkd.in/eYhXF2Ns #Lifescience #testing #efficacy #research #PDXmodel #invivomodels #CRO #drugdevelopment #ethicalpractice #NAM #nonclinical #biotech #TNBC

Want some insight into what's in store in the biotech industry in 2024? Ryght CEO Simon Arkell OLY recently participated in roundtable hosted by Genetic Engineering & Biotechnology News and moderated by Alex Philippidis where the panelists explored the issues that are driving their companies in the new year.   Listen in to Simon, Karen Zaderej, CEO of Axogen; and Neil McFarlane, CEO of Zevra Therapeutics here: https://lnkd.in/ecTvK3bz #2024predictions #biotech #genai

Hii Everyone, I'm Happy To Share That I've Obtained A New Certification: Participation In The 40th SPSR International Webinar On 'Adopting Genome Editing Technology In Combating Cancer Disease' Webinar Hosted By Society Of Pharmaceutical Sciences And Reasearch ( SPSR) On February 19th 2024. ~ Society of Pharmaceutical Sciences and Research & Managing Editor IJPSR ~Mrs.Monika Sabharwal #goals #spsr #research #science #cancerresearch #pharmaceuticalsciences The more you attend the webinar, the closer you get to your goals.

📢 Exciting News! The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer, and Merck. 🤝Together, we'll advance genomics, find actionable therapeutic targets, and bridge the gap in diverse genomic data. #Genomics #TherapeuticDevelopment #HealthcareInnovation #PrecisionMedicine Read the press here 👇👇👇

Looking forward to meeting friends and colleagues at SOT 24. Please consider attending this session if you are curious about toxicity prediction with omics data and machine learning for drug development acceleration! #multiomics #machinelearning #toxicity #drugdevelopment #drugdiscovery

Genetic Engineering & Biotechnology News’ Alex Philippidis recently spoke with Absci Founder & CEO Sean McClain to learn more about some of the exciting recent happenings at Absci. Topics included our oversubscribed underwritten public offering and continued development of our internal pipeline of AI-generated assets. Read the article here: https://lnkd.in/gNyAjWvr #Absci #pharma #biotech #AI

JW Group is the first domestic pharmaceutical company to install a zebrafish room at JW Gwacheon Tower. Zebrafish, which has 80% genetic similarity to humans, serves as an efficient model for preclinical translational research. Zebrafish provides faster and more effective experimental results compared to mammalian experiments. JW Group's zebrafish room can accommodate 900 zebrafish, and the sample analysis room can observe and analyze up to 96 fish at the same time. Meanwhile, JW Group is working hard to strengthen translational research using organoids by collaborating with Organoid Sciences and with J-PHIT for non-clinical trials using the zebrafish model. If you would like to know more about JW Group's zebrafish room, please click the link below. https://lnkd.in/g3yfHzh5 #JWGroup #Zebrafish #ZebrafishModel #TranslationalResearch #Organoids

Insightful video from AstraZeneca's Centre for Genomics Research. Here, Slavé Petrovski, VP, explains why AstraZeneca joined the Alliance for Genomic Discovery, alongside NashBio, Illumina, and 7 other pharma genomics pioneers. Their goal? To analyse 2 million genomes with a view to achieving 4 key objectives; - deliver novel insights into the biology of diseases; - enable the identification of new targets for medicines; - support selection of patients for clinical trials; - allow patients to be matched with treatments more likely to benefit them. Stay tuned for more updates on this ambitious initiative! The AGD Partners to date: Amgen AbbVie AstraZeneca Bayer Bristol Myers Squibb Merck MSD GSK Novo Nordisk NashBioIllumina #diseaseunderstanding #genomics #precisionmedicine #clinicaltrials #drugdiscovery

All four #biotech IPOs this year have come from mid- to late-stage companies, but Metagenomi is looking to buck that trend. https://lnkd.in/dDiYmemp #biotechnology #geneediting #genetherapy #genetics #Metagenomi #pharmaceuticals